We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
-0.82%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$273M
AUM Growth
-$28.6M
(-9.5%)
Cap. Flow
-$23M
Cap. Flow
% of AUM
-8.44%
Top 10 Holdings %
Top 10 Hldgs %
63.42%
Holding
36
New
6
Increased
4
Reduced
7
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$10M |
| 2 |
AKRO
Akero Therapeutics
AKRO
|
+$4.73M |
| 3 |
DexCom
DXCM
|
+$4.37M |
| 4 |
Tenet Healthcare
THC
|
+$4.37M |
| 5 |
Crown Holdings
CCK
|
+$3.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$13M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$12.4M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$10.5M |
| 4 |
Alcon
ALC
|
+$6.64M |
| 5 |
Sable Offshore Corp
SOC
|
+$4.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.45% |
| 2 | Consumer Discretionary | 22.51% |
| 3 | Technology | 17.72% |
| 4 | Communication Services | 10.96% |
| 5 | Financials | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Uber
UBER
$143B
| $23.4M | 8.58% |
509,357
-285,200
| -36% | -$13M |
|
2
Caesars Entertainment
CZR
$6.06B
| $19.8M | 7.27% |
427,925
-36,600
| -8% | -$1.94M |
|
3
Melco Resorts & Entertainment
MLCO
$2.26B
| $19.4M | 7.12% |
1,965,122
| – | – |
|
4
Charter Communications
CHTR
$17.4B
| $19.4M | 7.11% |
44,113
-6,800
| -13% | -$2.83M |
|
5
GoDaddy
GDDY
$10.5B
| $17.6M | 6.45% |
236,244
-33,559
| -12% | -$2.48M |
|
6
Teva Pharmaceuticals
TEVA
$40.9B
| $15.3M | 5.61% |
1,500,000
| – | – |
|
7
Eli Lilly
LLY
$1.02T
| $15.1M | 5.53% |
28,076
| – | – |
|
8
Morgan Stanley
MS
$332B
| $14.9M | 5.44% |
181,914
| – | – |
|
9
Vertex Pharmaceuticals
VRTX
$121B
| $14.7M | 5.4% |
42,400
| – | – |
|
10
Bath & Body Works
BBWI
$4.05B
| $13.4M | 4.91% |
396,327
+24,227
| +7% | +$880K |
|
11
US Foods
USFD
$22.1B
| $12.4M | 4.54% |
312,331
+65,900
| +27% | +$2.73M |
|
12
Biogen
BIIB
$30.3B
| $8.81M | 3.23% |
34,261
-12,372
| -27% | -$3.31M |
|
|
13
Crown Holdings
CCK
$12.8B
| $8.76M | 3.21% |
99,000
+43,900
| +80% | +$3.93M |
|
|
EDR
14
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $8.69M | 3.19% |
+436,860
| New | +$10M |
|
|
15
Alcon
ALC
$33.4B
| $7.8M | 2.86% |
101,227
-80,750
| -44% | -$6.64M |
|
|
IMGN
16
DELISTED
Immunogen Inc
IMGN
| $7.41M | 2.72% |
467,220
| – | – |
|
|
DCBO
17
Docebo
DCBO
$520M
| $6.36M | 2.33% |
156,892
+18,300
| +13% | +$725K |
|
|
AKRO
18
DELISTED
Akero Therapeutics
AKRO
| $5.13M | 1.88% |
+101,500
| New | +$4.73M |
|
19
Quanterix
QTRX
$164M
| $4.2M | 1.54% |
154,900
| – | – |
|
20
Bausch + Lomb
BLCO
$5.95B
| $4.16M | 1.52% |
245,431
| – | – |
|
21
Sotera Health
SHC
$5.09B
| $3.9M | 1.43% |
260,400
| – | – |
|
|
22
Tenet Healthcare
THC
$20.5B
| $3.85M | 1.41% |
+58,500
| New | +$4.37M |
|
|
23
DexCom
DXCM
$32.1B
| $3.62M | 1.33% |
+38,800
| New | +$4.37M |
|
24
Charles River Laboratories
CRL
$11.3B
| $3.45M | 1.26% |
+17,600
| New | +$3.61M |
|
25
Knife River
KNF
$4.23B
| $3.33M | 1.22% |
68,199
| – | – |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q3 2023 Portfolio in Review
As of Q3 2023, Bridger Management held 36 positions worth $273M, down 9.5% from $301M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Bridger Management withdrew a net $23M in Q3 2023, closing 4 positions and reducing 7 holdings. Its most notable exit was BioMarin Pharmaceuticals, an estimated $12.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Bridger Management opened a new position in Endeavor Group Holdings, Inc. worth $8.69M.
- Bridger Management's largest Q3 2023 buy was Endeavor Group Holdings, Inc.: 436,860 shares worth $8.69M.
- Bridger Management added most to Crown Holdings in Q3 2023, an estimated $3.93M increase.
- Bridger Management's biggest Q3 2023 reduction was Uber, cutting an estimated $13M.
- Bridger Management fully exited BioMarin Pharmaceuticals in Q3 2023, selling an estimated $12.4M.
- Bridger Management's ten largest holdings make up 63% of its $273M portfolio in Q3 2023.
- Bridger Management opened 6 new positions and closed 4 in Q3 2023.
- Bridger Management's portfolio value fell 9.5% quarter-over-quarter to $273M.
Based on Bridger Management's 13F filing for Q3 2023, filed 14 Nov 2023.